AU2003273854A1 - Method for refolding neisserial nspa protein - Google Patents

Method for refolding neisserial nspa protein

Info

Publication number
AU2003273854A1
AU2003273854A1 AU2003273854A AU2003273854A AU2003273854A1 AU 2003273854 A1 AU2003273854 A1 AU 2003273854A1 AU 2003273854 A AU2003273854 A AU 2003273854A AU 2003273854 A AU2003273854 A AU 2003273854A AU 2003273854 A1 AU2003273854 A1 AU 2003273854A1
Authority
AU
Australia
Prior art keywords
neisserial
refolding
nspa protein
nspa
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003273854A
Other languages
English (en)
Other versions
AU2003273854A8 (en
Inventor
Ralph Biemans
Martine Bos
Philippe Denoel
Christiane Feron
Carine Goraj
Jan Poolman
Jan Tommassen
Vincent Weynants
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Rijksuniversiteit Utrecht
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of AU2003273854A1 publication Critical patent/AU2003273854A1/en
Publication of AU2003273854A8 publication Critical patent/AU2003273854A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A61K39/1045—Moraxella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2003273854A 2002-08-30 2003-08-28 Method for refolding neisserial nspa protein Abandoned AU2003273854A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0220197.8A GB0220197D0 (en) 2002-08-30 2002-08-30 Refolding method
GB0220197.8 2002-08-30
PCT/EP2003/010085 WO2004020452A2 (fr) 2002-08-30 2003-08-28 Procede de repliement

Publications (2)

Publication Number Publication Date
AU2003273854A1 true AU2003273854A1 (en) 2004-03-19
AU2003273854A8 AU2003273854A8 (en) 2004-03-19

Family

ID=9943240

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273854A Abandoned AU2003273854A1 (en) 2002-08-30 2003-08-28 Method for refolding neisserial nspa protein

Country Status (8)

Country Link
US (2) US20080025993A1 (fr)
EP (1) EP1532168B1 (fr)
JP (2) JP4652808B2 (fr)
AU (1) AU2003273854A1 (fr)
CA (1) CA2496045A1 (fr)
ES (1) ES2505692T3 (fr)
GB (1) GB0220197D0 (fr)
WO (1) WO2004020452A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0220197D0 (en) * 2002-08-30 2002-10-09 Univ Utrecht Refolding method
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
EP2496597A4 (fr) * 2009-11-06 2013-08-14 Childrens Hosp & Res Ct Oak Protéine b stimulant les lymphocytes t et procédés d'utilisation
CA2815342A1 (fr) * 2010-10-20 2012-04-26 Medimmune, Llc Methodes de traitement de corps d'inclusion
WO2013177397A1 (fr) * 2012-05-24 2013-11-28 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Conjugués méningococciques multivalents et méthodes de préparation associées
WO2015120488A1 (fr) * 2014-02-10 2015-08-13 Mediatek Inc. Méthode d'identification de bss de source dans un wlan
BR102018003245A2 (pt) * 2018-02-20 2019-09-10 Fundação Oswaldo Cruz oligonucleotídeo, conjunto de oligonucleotídeos, método para detecção simultânea de neisseria meningitidis, streptococcus pneumoniae e haemophilus influenzae, e, kit.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117483A (en) * 1995-03-17 2008-03-20 Bernard Brodeur MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
EP2270174A1 (fr) * 1999-05-19 2011-01-05 Novartis Vaccines and Diagnostics S.r.l. Compositions à base de combinaisons de Neisseria
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB0007432D0 (en) * 2000-03-27 2000-05-17 Microbiological Res Authority Proteins for use as carriers in conjugate vaccines
GB0220197D0 (en) * 2002-08-30 2002-10-09 Univ Utrecht Refolding method

Also Published As

Publication number Publication date
US20080025993A1 (en) 2008-01-31
JP2006511463A (ja) 2006-04-06
EP1532168A2 (fr) 2005-05-25
ES2505692T3 (es) 2014-10-10
AU2003273854A8 (en) 2004-03-19
CA2496045A1 (fr) 2004-03-11
JP2011057679A (ja) 2011-03-24
WO2004020452A3 (fr) 2004-08-19
US20100291137A1 (en) 2010-11-18
GB0220197D0 (en) 2002-10-09
JP4652808B2 (ja) 2011-03-16
WO2004020452A2 (fr) 2004-03-11
EP1532168B1 (fr) 2014-07-23

Similar Documents

Publication Publication Date Title
AU2003287642A1 (en) Process for solubilizing protein
AU2003279766A1 (en) Microfluidic protein crystallography
AU2003211625A1 (en) Method of modifying protein properties
AU2003281175A1 (en) Method for examination about peritoneal function
AU2003232220A1 (en) Device for protein crystallisation
AU2003283174A1 (en) Method for protein production
AU2002952747A0 (en) Method for analysing peptides
AUPS160602A0 (en) Therapeutic method
AU2002364749A1 (en) Method for protein expression analysis
AU2003273854A1 (en) Method for refolding neisserial nspa protein
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003264657A1 (en) Method for designing peptides
EP1603386B8 (fr) Procede d'aquaculture
AU2003295462A1 (en) Lipid-associated proteins
AU2003246993A1 (en) Method for presenting fisheye-camera images
AU2003263161A1 (en) Method for making recombinant proteins
AU2003253813A1 (en) Method for colpoplasty
AU2003294206A1 (en) Methods for diagnosing htlv-i-mediated diseases
AU2003202694A1 (en) Torero protein
AU2003294117A1 (en) Suturing method
AU2003236374A1 (en) Atopic dermatitis-inducing proteins
AU2003206048A1 (en) Bread comprising soy protein
AU2002344604A1 (en) Method for making calendar
AU2003278718A1 (en) Stars-a muscle-specification-binding protein
AU2003270055A1 (en) Neurotransmission-associated proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase